Chryslain Sumian

Title: Chryslain Sumian: Innovator in Biological Fluid Filtration

Introduction

Chryslain Sumian is a notable inventor based in Lambersart, France. He has made significant contributions to the field of biological fluid filtration, particularly with his innovative patent that addresses the selective elimination of target substances from fluids.

Latest Patents

Chryslain Sumian holds one patent titled "Biological fluid filtration unit provided with an offset inlet and/or outlet member." This filtration unit is designed to allow the selective elimination of target substances from fluids such as blood components. The unit features an outer envelope formed from two flexible sheets that are joined together along a bond line, creating an inner volume. Inside the envelope, a filtering medium separates an inlet compartment for the fluid to be filtered and an outlet compartment for the filtrate. Each compartment is equipped with elements for communication with the outside, and the unique design includes at least one channel that is offset relative to the bond line.

Career Highlights

Chryslain Sumian is currently employed at Macopharma, a company known for its advancements in medical technologies. His work focuses on developing innovative solutions for fluid filtration, which has important applications in medical and biological fields.

Collaborations

Chryslain has collaborated with notable coworkers, including Robert Duhaut and David Godard. Their combined expertise contributes to the innovative projects at Macopharma.

Conclusion

Chryslain Sumian's contributions to biological fluid filtration exemplify the impact of innovation in medical technology. His patent reflects a commitment to improving fluid filtration processes, which can enhance medical treatments and patient care.